Residency · Residency · Pediatrics

Intraventricular Hemorrhage and Periventricular Leukomalacia

Overview

Intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL) are major causes of neurodevelopmental disability in preterm infants. IVH originates from the germinal matrix, a highly vascularized subependymal region that normally involutes by 34-36 weeks gestation. PVL represents ischemic white matter injury occurring in the periventricular watershed zones. Both conditions are predominantly diseases of prematurity, with incidence inversely related to gestational age.

Pathogenesis of IVH

Germinal Matrix Vulnerability

The germinal matrix is a transient embryonic structure containing a rich capillary network composed of immature, fragile blood vessels that lack the normal supporting structures found in mature vasculature. These vessels are end-arteries situated in a vascular watershed zone, making them particularly susceptible to perfusion changes. The germinal matrix involutes between 28 and 34 weeks gestation, which is why infants born before 32 weeks are most vulnerable to hemorrhage from this region.

Contributing Factors

Several factors converge to place the preterm germinal matrix at risk. Fluctuating cerebral blood flow is perhaps the most critical contributor, as preterm infants lack cerebral autoregulation. This means blood pressure changes are transmitted directly to the fragile germinal matrix capillaries without the buffering that autoregulation normally provides. Increased venous pressure from pneumothorax, high ventilator pressures, or vigorous suctioning can further stress these vessels. Coagulation immaturity, characterized by low levels of clotting factors and platelet dysfunction, impairs the infant's ability to contain even small hemorrhages. Perinatal events such as birth asphyxia, rapid volume expansion, and bicarbonate infusion contribute additional hemodynamic insults.

Timing

The timing of IVH is remarkably predictable: approximately 50% of hemorrhages occur within the first 24 hours of life, and 90% occur within the first 72 hours. Late-onset IVH occurring after 7 days is uncommon and should prompt evaluation for coagulopathy or vascular malformation.

Grading System (Papile Classification, Modified)

The severity of IVH is classified using the modified Papile grading system. Grade I hemorrhage is confined to the germinal matrix only (subependymal). Grade II involves blood within the lateral ventricle filling less than 50% of the ventricular space without ventricular distension. Grade III describes blood filling greater than 50% of the lateral ventricle with associated ventricular distension. Grade IV, now more accurately termed "periventricular hemorrhagic infarction" (PVHI), involves intraparenchymal hemorrhage. This is not simply an extension of intraventricular blood into the brain tissue; rather, it represents venous infarction caused by obstruction of the terminal veins by clot within the ventricle. It is characteristically asymmetric and usually unilateral, and it carries the worst neurodevelopmental prognosis.

Screening and Diagnosis

Cranial ultrasound (CUS) is the standard screening tool for IVH. The AAP recommends screening all infants born at less than 30 weeks gestation at 7-14 days of life, with a repeat study at 36-40 weeks postmenstrual age or before discharge. Some centers perform earlier screening at 3-7 days for clinical decision-making purposes. CUS findings include echogenic blood visible in the germinal matrix, ventricles, or parenchyma. MRI is superior to ultrasound for detecting white matter injury (PVL) and is typically obtained near term-equivalent age.

Clinical Presentation

Grade I and II hemorrhages are often clinically silent and detected only on routine screening ultrasound. Severe IVH (Grade III-IV) may present with sudden clinical deterioration including apnea, bradycardia, and hypotension. A falling hematocrit without obvious external bleeding is a classic laboratory finding. Physical examination may reveal a bulging fontanelle, and seizures may occur. Metabolic acidosis develops as the hemorrhage progresses. In catastrophic cases, rapid neurologic decline progressing to coma occurs.

Prevention Strategies

Antenatal corticosteroids represent the single most effective intervention for preventing IVH, reducing its incidence by approximately 50%. Delayed cord clamping for 30-60 seconds improves transitional hemodynamics and further reduces risk. After birth, the focus shifts to avoiding fluctuations in cerebral blood flow through gentle ventilation, avoidance of hyperventilation, slow volume expansion, midline head positioning to improve venous drainage, and minimal handling protocols during the first 72 hours of life. Indomethacin prophylaxis reduces severe IVH in extremely low birth weight infants but has not demonstrated improvement in long-term neurodevelopmental outcomes, and its use has declined. Early initiation of caffeine may also reduce IVH risk. Rapid bicarbonate infusion should be avoided because of the osmotic shifts it produces.

Posthemorrhagic Hydrocephalus (PHH)

Posthemorrhagic hydrocephalus complicates Grade III-IV IVH in 25-50% of cases. The mechanism involves blood and blood products obstructing CSF flow through the aqueduct or impairing CSF reabsorption at the arachnoid granulations. Monitoring requires serial head circumference measurements and cranial ultrasound tracking of the ventricular index.

Temporizing measures include serial lumbar punctures or ventricular taps, though evidence for their efficacy is limited. A ventricular access device (VAD or reservoir) can be placed subgaleally for repeated tapping to control ventricular distension. The DRIFT study investigated drainage, irrigation, and fibrinolytic therapy, which showed improved outcomes but carried higher secondary hemorrhage risk.

Definitive treatment consists of ventriculoperitoneal shunt (VPS) placement, typically deferred until the infant reaches adequate weight and CSF protein normalizes sufficiently to avoid shunt obstruction. Endoscopic third ventriculostomy with or without choroid plexus cauterization is an emerging alternative option.

Periventricular Leukomalacia (PVL)

Pathogenesis

PVL results from ischemic injury to the periventricular white matter in watershed zones between penetrating arteries. The critical cellular target is the pre-oligodendrocyte (pre-OL), which is exquisitely vulnerable to multiple insults including hypoxia-ischemia, inflammation from cytokines released during chorioamnionitis or sepsis, free radical injury, and excitotoxicity mediated by glutamate. PVL manifests in two forms: focal necrosis that evolves into periventricular cysts (cystic PVL), and diffuse white matter injury, which is more common and appears on MRI as diffuse excessive high signal intensity (DEHSI), ultimately leading to reduced white matter volume.

Clinical Significance

Cystic PVL is strongly associated with cerebral palsy, particularly spastic diplegia. Diffuse white matter injury correlates with cognitive, behavioral, and motor deficits that may be more subtle but nonetheless significant. The timing of injury often occurs in utero or perinatally, though diagnosis by imaging may not be possible until weeks later.

Diagnosis

On cranial ultrasound, PVL initially appears as periventricular echodensities that evolve into cystic lesions visible by 3-6 weeks. MRI at term-equivalent age is the gold standard for identifying diffuse white matter injury, reduced white matter volume, and ventriculomegaly ex vacuo (ventricular enlargement resulting from brain tissue loss rather than hydrocephalus).

Neurodevelopmental Outcomes

Outcomes after IVH and PVL are grade-dependent. Grade I-II IVH carries a generally favorable prognosis with only a mild increase in developmental concerns. Grade III IVH results in cerebral palsy or significant cognitive disability in 30-40% of affected infants. PVHI (Grade IV) leads to cerebral palsy (typically contralateral hemiplegia) and intellectual disability in 60-80% of cases. Cystic PVL carries the worst prognosis, with greater than 90% of affected infants developing cerebral palsy, most commonly spastic diplegia. All high-risk infants require structured neurodevelopmental follow-up programs.

<image>A coronal cross-section illustration of the preterm brain showing the germinal matrix location (subependymal region adjacent to the lateral ventricles), with four panels depicting the four grades of IVH: Grade I (hemorrhage confined to germinal matrix), Grade II (blood within ventricle without distension), Grade III (blood filling and distending the ventricle), and Grade IV/PVHI (parenchymal hemorrhagic infarction with asymmetric periventricular involvement). Labeled medical neuroanatomy illustration.</image>

<image>A cranial ultrasound illustration in the coronal and sagittal planes showing Grade III IVH with dilated ventricles filled with echogenic blood, and an adjacent panel showing cystic periventricular leukomalacia with anechoic cysts in the periventricular white matter. Include labeled anatomical landmarks (lateral ventricles, choroid plexus, germinal matrix region).</image>

<image>A diagram of the pathogenesis of periventricular leukomalacia, showing the periventricular watershed zones between penetrating arteries, the vulnerability of pre-oligodendrocytes to hypoxia-ischemia and inflammation, and the two outcomes: focal cystic necrosis and diffuse white matter injury. Include arrows showing contributing factors (chorioamnionitis, hypotension, sepsis) converging on the vulnerable zone. Medical illustration with labeled pathways.</image>

Clinical Pearls

Antenatal corticosteroids are the single most important intervention to reduce IVH and should be administered whenever preterm delivery is anticipated. Most IVH occurs in the first 72 hours of life, making minimal handling and gentle ventilation during this critical period essential prevention strategies. The term "Grade IV IVH" is a misnomer because it represents periventricular hemorrhagic venous infarction rather than simple extension of intraventricular blood into the parenchyma. Not all IVH leads to poor outcomes, and families should be counseled that Grade I-II hemorrhages generally carry a reassuring prognosis. Serial cranial ultrasound and head circumference monitoring are essential for detecting posthemorrhagic hydrocephalus, which requires timely intervention to prevent further brain injury. MRI near term-equivalent age is the best tool for detecting diffuse white matter injury that cranial ultrasound may miss entirely. Early referral to developmental follow-up and early intervention services is essential for all infants with significant IVH or PVL.

References

• Papile LA, et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529-534.
• Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009;8(1):110-124.
• Inder TE, et al. Defining the nature of the cerebral abnormalities in the premature infant: a qualitative MRI study. J Pediatr. 2003;143(2):171-179.
• Whitelaw A, et al. DRIFT study: randomized trial of drainage, irrigation, and fibrinolytic therapy for posthemorrhagic ventricular dilatation. Pediatrics. 2010;125(4):e852-e858.
• AAP Committee on Fetus and Newborn. Screening for IVH in preterm infants. Pediatrics. 2020;145(1):e20193000.

Read this lecture as Markdown